Patientsville.com

Do You Have a Question about Your Health?

We will help You understand Your condition and Feel better! Ask Our Health Experts!

Private, Confidential and Discreet Type your question here

 letters left

METRONIDAZOLE Safety Reports

Total METRONIDAZOLE reports: 165.
METRONIDAZOLE FDA safety alerts: No.
Reported deaths: 8    Reported hospitalizations: 71.
Take METRONIDAZOLE Side Effects Survey or Share Your METRONIDAZOLE Story. Read More Here.

Showing 1-75 of 165 Next >

Consumer or non-health professional from reported METRONIDAZOLE problem on July 19, 2006. Female patient, 41 years of age, weighting 132.3 lb, was diagnosed with abscess and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: fatigue, frequent bowel movements, joint stiffness. METRONIDAZOLE dosage: unknown. During the same period patient was treated with AMOXICILLIN. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2006. Female patient, 46 years of age, weighting 108.0 lb, was diagnosed with vaginitis bacterial and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: arthralgia, dysgeusia, headache, nausea, pyrexia, stomach discomfort, vomiting. METRONIDAZOLE dosage: unknown. Patient recovered.

Physician from KOREA, REPUBLIC OF reported METRONIDAZOLE problem on Aug 08, 2006. Male patient, 51 years of age, was diagnosed with pseudomembranous colitis and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: hepatic failure, renal failure. METRONIDAZOLE dosage: 1000 MG (EVERYDAY), INTRAVENOUS. Patient died.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from on Aug 21, 2006. Male patient, 42 years of age, was diagnosed with helicobacter infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: meningitis aseptic. METRONIDAZOLE dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported METRONIDAZOLE problem on Apr 20, 2006. Female patient, 60 years of age, was diagnosed with urinary tract infection, pulmonary embolism and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, deep vein thrombosis, haemoglobin decreased, hypovolaemic shock, international normalised ratio increased, muscle haemorrhage, pyrexia. METRONIDAZOLE dosage: unknown. During the same period patient was treated with TRIMETHOPRIN, CEPHALEXIN, WARFARIN, NIFEDIPINE, ACEBUTOLOL, INDAPAMIDE. Patient was hospitalized. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from on May 04, 2006. Female patient, 60 years of age, was diagnosed with urinary tract infection, pulmonary embolism and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, deep vein thrombosis, haemoglobin decreased, hypovolaemic shock, international normalised ratio increased, muscle haemorrhage, pyrexia. METRONIDAZOLE dosage: unknown. During the same period patient was treated with WARFARIN, CEPHALEXIN, TRIMETHOPRIM, NIFEDIPINE, ACEBUTOLOL, INDAPAMIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported METRONIDAZOLE problem on Aug 21, 2006. Male patient, 42 years of age, was diagnosed with helicobacter infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: headache, meningism, meningitis aseptic, photophobia. METRONIDAZOLE dosage: unknown. Patient was hospitalized. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from DENMARK on Aug 17, 2006. Female patient, 32 years of age, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: breech presentation, caesarean section, hyperlipidaemia, hypothyroidism, medical diet, pre-eclampsia, premature baby, small for dates baby. METRONIDAZOLE dosage: unknown. During the same period patient was treated with AMPICILLIN TRIHYDRATE, ZINACEF, LEVOTHYROXINE. Patient recovered.

Consumer or non-health professional from reported METRONIDAZOLE problem on Aug 24, 2006. Female patient, weighting 136.7 lb, was diagnosed with pelvic infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: anorexia, arthralgia, heart rate increased, hypoaesthesia, nausea, palpitations, swelling. METRONIDAZOLE dosage: unknown. During the same period patient was treated with OFLOXACIN. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 21, 2006. Male patient, 42 years of age, was diagnosed with helicobacter infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: meningitis aseptic. METRONIDAZOLE dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported METRONIDAZOLE problem on Sept 07, 2006. Male patient, 87 years of age, weighting 210.1 lb, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, rash. METRONIDAZOLE dosage: 500 MG , TID, BY MOUTH. During the same period patient was treated with ACETAMINOPHEN, OXYCODONE, FERROUS SULPHATE, HEPARIN, VITAMIN, SYNTHROID, DARBEPOETIN ALFA. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from on Sept 07, 2006. Female patient, 59 years of age, was diagnosed with tooth abscess, pain and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: dizziness, dry mouth, pharyngolaryngeal pain, urticaria. METRONIDAZOLE dosage: unknown. During the same period patient was treated with DICLOFENAC. Patient recovered.

Consumer or non-health professional from UNITED STATES reported METRONIDAZOLE problem on Aug 29, 2006. Female patient, 38 years of age, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: caesarean section, pregnancy, premature rupture of membranes, stillbirth. METRONIDAZOLE dosage: unknown. Patient died.

METRONIDAZOLE problem was reported by a Pharmacist from UNITED STATES on Sept 18, 2006. Female patient was diagnosed with intestinal obstruction and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: tachycardia. METRONIDAZOLE dosage: 500 MG Q 8 HOURS IV DRIP. Patient recovered.

Health Professional from UNITED KINGDOM reported METRONIDAZOLE problem on Aug 30, 2006. Female patient, 60 years of age, was diagnosed with urinary tract infection, pulmonary embolism and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, deep vein thrombosis, haemoglobin decreased, hypovolaemic shock, international normalised ratio increased, muscle haemorrhage, pyrexia. METRONIDAZOLE dosage: unknown. During the same period patient was treated with WARFARIN, CEPHALEXIN, TRIMETHOPRIM, NIFEDIPINE, ACEBUTOLOL, INDAPAMIDE. Patient was hospitalized. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 08, 2006. Female patient, 59 years of age, was diagnosed with tooth abscess and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: dizziness, dry mouth, pharyngolaryngeal pain, urticaria. METRONIDAZOLE dosage: 400 MG, TID, ORAL. During the same period patient was treated with DICLOFENAC, NEOCLARITYN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported METRONIDAZOLE problem on Sept 15, 2006. Female patient, 15 years of age, was diagnosed with vaginal infection, urinary tract infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: autonomic neuropathy, diarrhoea, erythema, feeling cold, oedema peripheral. METRONIDAZOLE dosage: unknown. During the same period patient was treated with SULFAMETHOXAZOLE. Patient was hospitalized. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 11, 2006. Female patient, 77 years of age, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: liver function test abnormal. METRONIDAZOLE dosage: 400 MG, BID, ORAL. During the same period patient was treated with FLUCONAZOLE, PIPERACILLIN AND TAZOBACTAM, ACETYLCYSTEINE, AMLODIPINE, CODEINE SUL, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported METRONIDAZOLE problem on Sept 12, 2006. Female patient, 28 years of age, weighting 338.9 lb, was diagnosed with vaginitis bacterial and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. METRONIDAZOLE dosage: unknown. During the same period patient was treated with SYNTHROID. Patient died.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from NETHERLANDS on Sept 21, 2006. Female patient, 43 years of age, was diagnosed with gingivitis and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. METRONIDAZOLE dosage: unknown. During the same period patient was treated with AMOXICILLIN, CEFUROXIME. Patient recovered.

Physician from UNITED STATES reported METRONIDAZOLE problem on Sept 29, 2006. Male patient, 57 years of age, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: appendicitis, clostridium difficile colitis, colitis ischaemic, diarrhoea, gastrointestinal disorder, large intestine perforation, megacolon, systemic inflammatory response syndrome. METRONIDAZOLE dosage: 500MG TID PO. During the same period patient was treated with VANCOMYCIN. Patient was hospitalized and became disabled. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from on Oct 06, 2006. Female patient, 34 years of age, weighting 138.9 lb, was diagnosed with endometritis and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: dysgeusia, foreign body trauma. METRONIDAZOLE dosage: unknown. During the same period patient was treated with CEFADROXIL. Patient recovered.

Pharmacist from UNITED STATES reported METRONIDAZOLE problem on Oct 19, 2006. Male patient, 42 years of age, weighting 186.1 lb, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: rash, swollen tongue. METRONIDAZOLE dosage: unknown. During the same period patient was treated with DIPHENHYDRAMINE, PREDNISONE, PROCHLORPERAZINE MALEATE, LOPERAMIDE, NAPROXEN, KETOROLAC TROMETHAMINE, OXYCODONE. Patient was hospitalized. Patient recovered.

METRONIDAZOLE problem was reported by a Pharmacist from UNITED STATES on Oct 19, 2006. Male patient, 88 years of age, weighting 169.1 lb, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: nausea, vomiting. METRONIDAZOLE dosage: unknown. During the same period patient was treated with TRAZODONE, SYNTHROID, CYANOCOBALAMIN, SIMVASTATIN, ISOSORBIDE MONONITRATE, CITALOPRAM HYDROBROMIDE, ASPIRIN, TOLTERODINE TARTRATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported METRONIDAZOLE problem on Oct 06, 2006. Female patient, 34 years of age, weighting 138.9 lb, was diagnosed with endometritis and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: dysgeusia, foreign body trauma. METRONIDAZOLE dosage: 400 MG, ORAL. During the same period patient was treated with CEFADROXIL. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 09, 2006. Female patient, 18 years of age, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, acute respiratory distress syndrome, appendicectomy, procedural complication. METRONIDAZOLE dosage: unknown. During the same period patient was treated with CEFUROXIME AXETIL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported METRONIDAZOLE problem on Oct 17, 2006. Female patient, 18 years of age, was diagnosed with pyrexia and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, acute respiratory distress syndrome, vaginal haemorrhage. METRONIDAZOLE dosage: unknown. During the same period patient was treated with CEFUROXIME AXETIL, ETHER. Patient was hospitalized. Patient recovered.

METRONIDAZOLE problem was reported by a Health Professional from UNITED KINGDOM on Oct 19, 2006. Female patient, 18 years of age, was diagnosed with pyrexia, anaesthesia and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, acute respiratory distress syndrome, appendicectomy, vaginal haemorrhage. METRONIDAZOLE dosage: unknown. During the same period patient was treated with ANAESTHETIC ETHER, CEFUROXIME AXETIL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported METRONIDAZOLE problem on Oct 09, 2006. Female patient, 15 years of age, was diagnosed with vaginal infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: neuropathy peripheral. METRONIDAZOLE dosage: unknown. Patient was hospitalized. Patient recovered.

METRONIDAZOLE problem was reported by a Health Professional from FRANCE on Oct 13, 2006. Male patient, 44 years of age, weighting 194.0 lb, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, cholelithiasis, cholestasis, cytolytic hepatitis, diarrhoea, fungal infection, hepatosplenomegaly, hypersensitivity. METRONIDAZOLE dosage: (500 MG, 2 IN 1 D), OTHER. During the same period patient was treated with CYTARABINE, AMBISOME, CIPROFLOXACIN, DAUNORUBICIN, ACYCLOVIR, CASPOFUNGIN ACETATE, ALLOPURINOL, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported METRONIDAZOLE problem on Oct 16, 2006. Female patient, 15 years of age, was diagnosed with urinary tract infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: autonomic nervous system imbalance, diarrhoea, pain in extremity. METRONIDAZOLE dosage: unknown. Patient was hospitalized. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from PORTUGAL on Oct 26, 2006. Male patient, 33 years of age, was diagnosed with liver abscess and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: cerebellar ataxia, cerebellar syndrome, neurotoxicity, pain in extremity. METRONIDAZOLE dosage: unknown. During the same period patient was treated with CEFTRIAXONE. Patient recovered.

Consumer or non-health professional from reported METRONIDAZOLE problem on Oct 27, 2006. Female patient, 40 years of age, weighting 149.0 lb, was diagnosed with infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: dizziness, malaise, vomiting. METRONIDAZOLE dosage: unknown. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 06, 2006. Female patient, 45 years of age, weighting 240.0 lb, was diagnosed with diverticulitis and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: rash pruritic, stomach discomfort, urticaria. METRONIDAZOLE dosage: 1 500MG TABLET 3X A DAY PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported METRONIDAZOLE problem on Nov 07, 2006. Female patient, weighting 142.0 lb, was diagnosed with gastric infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: diplopia. METRONIDAZOLE dosage: unknown. Patient recovered.

METRONIDAZOLE problem was reported by a Physician from NETHERLANDS on Oct 09, 2006. Female patient, 43 years of age, was diagnosed with gingivitis and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: skin test positive, stevens-johnson syndrome. METRONIDAZOLE dosage: unknown. During the same period patient was treated with AMOXICILLIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported METRONIDAZOLE problem on Nov 02, 2006. Female patient, 18 years of age, was diagnosed with pyrexia and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, acute respiratory distress syndrome, post procedural complication, pregnancy test urine negative, pregnancy test urine positive, vaginal haemorrhage. METRONIDAZOLE dosage: unknown. During the same period patient was treated with CEFUROXIME AXETIL. Patient recovered.

METRONIDAZOLE problem was reported by a Pharmacist from UNITED STATES on Nov 09, 2006. Male patient, 57 years of age, was diagnosed with helicobacter infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: pruritus, rash. METRONIDAZOLE dosage: unknown. During the same period patient was treated with AMOXICILLIN. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported METRONIDAZOLE problem on Oct 30, 2006. Female patient, 40 years of age, weighting 149.0 lb, was diagnosed with infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: dizziness, malaise, vomiting. METRONIDAZOLE dosage: unknown. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 30, 2006. Female patient, 63 years of age, weighting 141.1 lb, was diagnosed with tooth abscess and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, epilepsy. METRONIDAZOLE dosage: 400 MG, TID, ORAL. During the same period patient was treated with BENDROFLUAZIDE. Patient recovered.

Consumer or non-health professional from ITALY reported METRONIDAZOLE problem on Nov 16, 2006. Female patient, 44 years of age, was diagnosed with respiratory tract infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: toxic epidermal necrolysis. METRONIDAZOLE dosage: unknown. During the same period patient was treated with PIPERACILLIN. Patient was hospitalized. Patient recovered.

METRONIDAZOLE problem was reported by a Physician from ITALY on Nov 08, 2006. Female patient, 44 years of age, was diagnosed with lung infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: acinetobacter infection, sepsis, toxic epidermal necrolysis. METRONIDAZOLE dosage: unknown. During the same period patient was treated with PIPERACILLIN. Patient died.

Health Professional from UNITED KINGDOM reported METRONIDAZOLE problem on Nov 09, 2006. Female patient, 64 years of age, was diagnosed with tooth disorder and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: vitreous detachment. METRONIDAZOLE dosage: (400 MG) ORAL. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from NETHERLANDS ANTILLES on Nov 16, 2006. Female patient, 43 years of age, was diagnosed with gingivitis and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. METRONIDAZOLE dosage: unknown. During the same period patient was treated with AMOXICILLIN, CEFUROXIME. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported METRONIDAZOLE problem on Nov 16, 2006. Female patient, 64 years of age, weighting 121.3 lb, was diagnosed with tooth disorder and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: vitreous detachment. METRONIDAZOLE dosage: 400 MG, ORAL. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 22, 2006. Male patient was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: convulsion, malaise. METRONIDAZOLE dosage: 400 MG. During the same period patient was treated with EPANUTIN, LAMOTRIGINE. Patient recovered.

Consumer or non-health professional from reported METRONIDAZOLE problem on Nov 29, 2006. Male patient, 64 years of age, weighting 176.4 lb, was diagnosed with gastroenteritis, diabetes mellitus and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia. METRONIDAZOLE dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, MIXTARD, TAMSULOSIN. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 23, 2006. Male patient, 64 years of age, was diagnosed with gastroenteritis and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia. METRONIDAZOLE dosage: 400 MG. Patient recovered.

Consumer or non-health professional from reported METRONIDAZOLE problem on Nov 07, 2006. Female patient, 27 years of age, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, oligohydramnios, pregnancy, premature rupture of membranes, twin pregnancy. METRONIDAZOLE dosage: unknown. During the same period patient was treated with ERYTHROMYCIN, CEFUROXIME, BETAMETHASONE. Patient recovered.

METRONIDAZOLE problem was reported by a Pharmacist from UNITED STATES on Dec 07, 2006. Female patient, 37 years of age, weighting 143.3 lb, was diagnosed with vaginal infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: body temperature increased, cough, leukocytoclastic vasculitis, oedema, oliguria, rash maculo-papular. METRONIDAZOLE dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported METRONIDAZOLE problem on Dec 05, 2006. Female patient, 27 years of age, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, premature rupture of membranes, twin pregnancy, vaginal haemorrhage. METRONIDAZOLE dosage: unknown. During the same period patient was treated with CEFUROXIME, ERYTHROMYCIN, BETAMETHASONE. Patient died.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from on Dec 08, 2006. Female patient, weighting 132.3 lb, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: hepatitis. METRONIDAZOLE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported METRONIDAZOLE problem on Dec 01, 2006. Male patient, 64 years of age, weighting 176.4 lb, was diagnosed with gastroenteritis and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia. METRONIDAZOLE dosage: 400 MG, ORAL. During the same period patient was treated with ATORVASTATIN CALCIUM, MIXTARD PORK, TAMSULOSIN. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 07, 2006. Female patient, 27 years of age, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, amniotic fluid volume decreased. METRONIDAZOLE dosage: unknown. During the same period patient was treated with BETAMETHASONE, CEFUROXIME, ERYTHROMYCIN. Patient died.

Consumer or non-health professional from UNITED KINGDOM reported METRONIDAZOLE problem on Dec 11, 2006. Female patient was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: hepatitis. METRONIDAZOLE dosage: (200 MG). Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 12, 2006. Female patient, weighting 132.3 lb, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: hepatitis. METRONIDAZOLE dosage: 200 MG, ORAL. Patient recovered.

Health Professional from UNITED STATES reported METRONIDAZOLE problem on June 29, 2007. Female patient, 58 years of age, was diagnosed with vaginal infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: asthenia, blood lactate dehydrogenase increased, blood urea decreased, chest pain, chills, disseminated intravascular coagulation, haematocrit decreased, haematuria, haemoglobin decreased. METRONIDAZOLE dosage: unknown. During the same period patient was treated with SERTRALINE, QUETIAPINE, LORAZEPAM, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.

METRONIDAZOLE problem was reported by a Pharmacist from UNITED STATES on July 16, 2007. Female patient, 29 years of age, was diagnosed with vaginitis bacterial and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, paraesthesia. METRONIDAZOLE dosage: 500MG QID PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported METRONIDAZOLE problem on July 18, 2007. Female patient, 64 years of age, weighting 118.0 lb, was diagnosed with lung neoplasm, clostridial infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: clostridial infection, depression, headache, movement disorder, pain, pain in extremity. METRONIDAZOLE dosage: 750 MG. 3 X A DAY PO. Patient recovered.

METRONIDAZOLE problem was reported by a Health Professional from UNITED KINGDOM on July 12, 2007. Male patient, 54 years of age, was diagnosed with schizophrenia and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: abdominal infection, blood albumin decreased, catabolic state, ileus, intestinal functional disorder, laparotomy, life support, malaise, sepsis. METRONIDAZOLE dosage: unknown. During the same period patient was treated with CLOZARIL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported METRONIDAZOLE problem on July 18, 2007. Female patient, 25 years of age, weighting 180.0 lb, was diagnosed with vaginal discharge, vaginal infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: cervicitis, dizziness, fatigue, vaginal haemorrhage. METRONIDAZOLE dosage: unknown. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from PORTUGAL on July 17, 2007. Female patient, 52 years of age, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: diarrhoea. METRONIDAZOLE dosage: unknown. During the same period patient was treated with CIPRALEX, MEDIPAX. Patient recovered.

Consumer or non-health professional from reported METRONIDAZOLE problem on Apr 12, 2007. Male patient, 23 years of age, was diagnosed with duodenal ulcer and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: hiccups. METRONIDAZOLE dosage: unknown. During the same period patient was treated with CLARITHROMYCIN, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

METRONIDAZOLE problem was reported by a Pharmacist from UNITED STATES on July 13, 2007. Female patient, 58 years of age, was diagnosed with vaginal infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: blood pressure diastolic increased, chest pain, haematuria, headache, microangiopathic haemolytic anaemia, pyrexia, renal failure, thrombotic thrombocytopenic purpura, vomiting. METRONIDAZOLE dosage: unknown. During the same period patient was treated with SERTRALINE, QUETIAPINE, LORAZEPAM, ZOLPIDEM TARTRATE. Patient recovered.

Consumer or non-health professional from reported METRONIDAZOLE problem on July 18, 2007. Male patient, 59 years of age, weighting 160.9 lb, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: peroneal nerve palsy. METRONIDAZOLE dosage: unknown. During the same period patient was treated with CEPHALEXIN. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2007. Female patient, 58 years of age, was diagnosed with vaginal infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: asthenia, chest pain, chills, haematuria, headache, lethargy, nausea, pyrexia, thrombotic thrombocytopenic purpura. METRONIDAZOLE dosage: unknown. During the same period patient was treated with SERTRALINE, QUETIAPINE FUMARATE, LORAZEPAM, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported METRONIDAZOLE problem on July 23, 2007. Female patient, 44 years of age, weighting 132.3 lb, was diagnosed with white blood cell count increased, anxiety and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, dyspnoea, rash pruritic, wheezing. METRONIDAZOLE dosage: unknown. During the same period patient was treated with CEFRADINE, DIAZEPAM, NITRAZEPAM, OMEPRAZOLE, QUININE SULPHATE. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 23, 2007. Female patient, 44 years of age, weighting 132.3 lb, was diagnosed with white blood cell count increased and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. METRONIDAZOLE dosage: 400 MG, ORAL. During the same period patient was treated with CEPHRADINE, DIAZEPAM, NITRAZEPAM, OMEPRAZOLE, QUININE SULPHATE. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported METRONIDAZOLE problem on July 27, 2007. Female patient, 22 years of age, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, dizziness, headache, myalgia, pollakiuria. METRONIDAZOLE dosage: 200 MG, TID, ORAL. During the same period patient was treated with AMOXICILLIN, CHLORHEXIDINE GLUCONATE. Patient recovered.

METRONIDAZOLE problem was reported by a Health Professional from UNITED KINGDOM on July 23, 2007. Female patient, 44 years of age, was diagnosed with white blood cell count increased and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. METRONIDAZOLE dosage: 400 MG, ORAL. During the same period patient was treated with CEFRADINE. Patient recovered.

Consumer or non-health professional from reported METRONIDAZOLE problem on Aug 02, 2007. Female patient, 45 years of age, weighting 198.4 lb, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: pustular psoriasis. METRONIDAZOLE dosage: unknown. Patient was hospitalized. Patient recovered.

METRONIDAZOLE problem was reported by a Consumer or non-health professional from PORTUGAL on Aug 01, 2007. Female patient, 52 years of age, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: diarrhoea. METRONIDAZOLE dosage: unknown. During the same period patient was treated with CIPRALEX, MEDIPAX. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported METRONIDAZOLE problem on Aug 02, 2007. Female patient, 45 years of age, weighting 198.4 lb, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: pustular psoriasis. METRONIDAZOLE dosage: unknown. Patient was hospitalized. Patient recovered.

METRONIDAZOLE problem was reported by a Pharmacist from UNITED STATES on Aug 13, 2007. Male patient, 58 years of age, was diagnosed with gastroenteritis and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: pancreatitis. METRONIDAZOLE dosage: 500MG TID PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported METRONIDAZOLE problem on Aug 02, 2007. Female patient, 45 years of age, was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: pustular psoriasis. METRONIDAZOLE dosage: unknown. Patient was hospitalized. Patient recovered.

Showing 1-75 of 165 Next >